SEC Form 4 · accession 0000899243-17-010064
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott A. Kelly
Director
Period of report
Apr 10, 2017
Accepted (ET)
Apr 12, 2017 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.61 | Apr 10, 2017 | A | 7,123 | A | May 31, 2017 | Apr 10, 2027 | Common Stock | 7,123 | 7,123 | D |
Explanation of responses
- F1Subject to stockholder approval of the increase in the number of shares of common stock authorized for issuance under the CytoDyn Inc. 2012 Equity Incentive Plan, as amended, at the next annual meeting.